Upregulation of ATP-Sensitive Potassium Channels as the Potential Mechanism of Cardioprotection and Vasorelaxation Under the Action of Pyridoxal-5-Phosphate in Old Rats.

IF 2.5 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Ruslan B Strutynskyi, Nataliіa A Strutynska, Oksana O Piven, Lidiia A Mys, Yulia V Goshovska, Raisa A Fedichkina, Iryna Y Okhai, Vladyslav R Strutynskyi, Victor E Dosenko, Pawel Dobrzyn, Vadim F Sagach
{"title":"Upregulation of ATP-Sensitive Potassium Channels as the Potential Mechanism of Cardioprotection and Vasorelaxation Under the Action of Pyridoxal-5-Phosphate in Old Rats.","authors":"Ruslan B Strutynskyi, Nataliіa A Strutynska, Oksana O Piven, Lidiia A Mys, Yulia V Goshovska, Raisa A Fedichkina, Iryna Y Okhai, Vladyslav R Strutynskyi, Victor E Dosenko, Pawel Dobrzyn, Vadim F Sagach","doi":"10.1177/10742484231213175","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> The aging process is accompanied by the weakening of the protective systems of the organism, in particular by the decrease in the expression of ATP-sensitive potassium (K<sub>ATP</sub>) channels and in the synthesis of H<sub>2</sub>S. The aim of our work was to investigate the role of K<sub>ATP</sub> channels in the cardioprotection induced by pyridoxal-5-phosphate (PLP) in aging. <b>Methods:</b> Experiments were performed on adult and old (aged 24 months) male Wistar rats, which were divided into 3 groups: adults, old, and old PLP-treated rats. PLP was administered orally once a day for 14 days at a dose of 0.7 mg/kg. The levels of mRNA expression of subunits K<sub>ATP</sub> channels were determined by reverse transcription and real-time polymerase chain reaction analysis. Protein expression levels were determined by the Western blot. Cardiac tissue morphology was determined using transverse 6 μm deparaffinized sections stained with picrosirius red staining. Vasorelaxation responses of isolated aortic rings and the function of Langendorff-perfused isolated hearts during ischemia-reperfusion, H<sub>2</sub>S levels, and markers of oxidative stress were also studied. <b>Results:</b> Administration of PLP to old rats reduces cardiac fibrosis and improves cardiac function during ischemia-reperfusion and vasorelaxation responses to K<sub>ATP</sub> channels opening. At the same time, there was a significant increase in mRNA and protein expression of SUR2 and Kir6.1 subunits of K<sub>ATP</sub> channels, H<sub>2</sub>S production, and reduced markers of oxidative stress. The specific K<sub>ATP</sub> channel inhibitor-glibenclamide prevented the enhancement of vasodilator responses and anti-ischemic protection in PLP-treated animals. <b>Conclusions:</b> We suggest that this potential therapeutic effect of PLP in old animals may be a result of increased expression of K<sub>ATP</sub> channels and H<sub>2</sub>S production.</p>","PeriodicalId":15281,"journal":{"name":"Journal of Cardiovascular Pharmacology and Therapeutics","volume":"28 ","pages":"10742484231213175"},"PeriodicalIF":2.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Pharmacology and Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10742484231213175","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The aging process is accompanied by the weakening of the protective systems of the organism, in particular by the decrease in the expression of ATP-sensitive potassium (KATP) channels and in the synthesis of H2S. The aim of our work was to investigate the role of KATP channels in the cardioprotection induced by pyridoxal-5-phosphate (PLP) in aging. Methods: Experiments were performed on adult and old (aged 24 months) male Wistar rats, which were divided into 3 groups: adults, old, and old PLP-treated rats. PLP was administered orally once a day for 14 days at a dose of 0.7 mg/kg. The levels of mRNA expression of subunits KATP channels were determined by reverse transcription and real-time polymerase chain reaction analysis. Protein expression levels were determined by the Western blot. Cardiac tissue morphology was determined using transverse 6 μm deparaffinized sections stained with picrosirius red staining. Vasorelaxation responses of isolated aortic rings and the function of Langendorff-perfused isolated hearts during ischemia-reperfusion, H2S levels, and markers of oxidative stress were also studied. Results: Administration of PLP to old rats reduces cardiac fibrosis and improves cardiac function during ischemia-reperfusion and vasorelaxation responses to KATP channels opening. At the same time, there was a significant increase in mRNA and protein expression of SUR2 and Kir6.1 subunits of KATP channels, H2S production, and reduced markers of oxidative stress. The specific KATP channel inhibitor-glibenclamide prevented the enhancement of vasodilator responses and anti-ischemic protection in PLP-treated animals. Conclusions: We suggest that this potential therapeutic effect of PLP in old animals may be a result of increased expression of KATP channels and H2S production.

ATP敏感性钾通道的上调是5-磷酸吡哆醇作用下老年大鼠心脏保护和血管舒张的潜在机制。
背景:衰老过程伴随着生物体保护系统的减弱,特别是ATP敏感性钾(KATP)通道的表达和H2S的合成减少。我们的工作目的是研究KATP通道在5-磷酸吡哆醛(PLP)诱导的衰老心脏保护中的作用。方法:采用成年和老年(24月龄)雄性Wistar大鼠进行实验,将其分为3组:成年、老年和老年PLP处理大鼠。PLP以0.7的剂量每天口服一次,持续14天 mg/kg。通过逆转录和实时聚合酶链反应分析测定KATP通道亚基的mRNA表达水平。蛋白质表达水平通过蛋白质印迹测定。使用横向6 μm的脱蜡切片用苦果红染色。还研究了离体主动脉环的血管舒张反应和Langendorff灌注的离体心脏在缺血再灌注过程中的功能、H2S水平和氧化应激标志物。结果:在缺血再灌注和KATP通道开放引起的血管舒张反应中,老年大鼠给予PLP可减少心脏纤维化并改善心脏功能。同时,KATP通道的SUR2和Kir6.1亚基的mRNA和蛋白质表达显著增加,H2S产生,氧化应激标志物减少。特异性KATP通道抑制剂格列本脲阻止了PLP治疗动物血管舒张反应和抗缺血保护的增强。结论:我们认为PLP在老年动物中的这种潜在治疗作用可能是KATP通道表达和H2S产生增加的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.00
自引率
0.00%
发文量
33
审稿时长
6-12 weeks
期刊介绍: Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) is a peer-reviewed journal that publishes original basic human studies, animal studies, and bench research with potential clinical application to cardiovascular pharmacology and therapeutics. Experimental studies focus on translational research. This journal is a member of the Committee on Publication Ethics (COPE).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信